Tag: venous stenting
Longer fasting before venography appears to impact stent size selection, new...
During the 2024 American Venous Forum (AVF) annual meeting in Tampa, Florida (March 3–6), Kurt S. Schultz, MD, a general surgery resident at the...
STEVECO trial provides “important evidence” in quest for individualized venous treatment
This advertorial, sponsored by Optimed, is only available in selected countries and geographies.
One-year results from the STEVECO randomized controlled trial (RCT) were recently...
Venous News’ top stories of 2023
Which stories captured the attention of the venous community this year? Read our summary of the trending articles from across the Venous News network...
Erin Murphy
“Occasionally, taking a step in a different direction can pave the way for substantial strides forward,” Erin Murphy, MD, tells Venous News, recalling her...
Primary patency after venous stenting best in NIVL patients, study finds
A recent study concludes that non-thrombotic iliac vein lesion (NIVL) patients have better primary patency after venous stenting than patients with venous thrombotic disorders....
CX 2023 seeks consensus in “rapidly” progressing venous field
The CX 2023 Venous & Lymphatic programme it set to be a “highlight” of this year’s meeting, CX co-chair and executive board member Erin...
STEVECO trial calls into question randomisation in the venous stenting field
Recruitment proved to be a major challenge for the STEVECO (Stent versus conservative treatment in patients with deep venous obstruction) randomised controlled trial (RCT),...
Venous stenting: “We need to evaluate use, appropriateness and clinical indication”
An analysis of venous stent usage trends in the USA from 2014 to 2021 showed a “significant increase” in stents per day placed over...
Educate, educate, and educate again: The continuing quest for appropriate venous...
Prominent venous disease experts discuss venous stenting, appropriate care, and the pursuit of refined data and better education in a space where part of...
Early results and expert experience positive for the BeYond dedicated venous...
This advertorial is sponsored by Bentley.
Launched in July 2020, the BeYond Venous self-expanding stent system (Bentley InnoMed GmbH) now has early clinical data and...
Retrospective study is “first to systematically explore predictors of venous stent...
New data indicate that venous stent failure “may be predicted by low peak flow velocity and post-thrombotic changes in inflow veins” and that endovascular...
Optimed announces the presentation of two prospective venous stent trials at...
Optimed recently announced the presentation of two prospective, multicentre trials evaluating the performance and effectiveness of their venous stent systems at the Leipzig Interventional...
“Excellent outcomes” for Zilver Vena® venous stent sustained out to three...
This advertorial is sponsored by Cook Medical.
The Zilver Vena venous self-expanding stent system (Cook Medical) is associated with high rates of patency by ultrasound,...
Overtreatment in venous disease: Financial incentives are “the elephant in the...
To combat the “overtreatment problem” in the appropriate care of venous disease, “a concerted, complex, multimodal effort” is required from specialists across disparate parts...
Dedicated vs. non-dedicated: Researchers place venous stenting under the spotlight at...
Venous stenting was a hot topic on the agenda of the recent American Venous Forum (AVF) annual meeting (23–26 February, Orlando, USA). Catching the audience’s...
CX 2022 venous and lymphatic challenges: “We are at a turning...
This year’s venous and lymphatic programme at the Charing Cross (CX) International Symposium 2022 (26–28 April, London, UK, in person and virtual) will cover...
Risk of venous stent migration rare but probably underreported, systematic review...
Stent migration following treatment of acute iliofemoral thrombus or venous obstruction is “rare but may be underreported”, with the majority of reported cases being...
Researchers find little benefit to stenting for degree of stenosis in...
A new study suggests that the degree of intravascular ultrasound (IVUS)-determined iliofemoral venous stenosis does not appear to affect the initial clinical presentation, clinical-etiologic-anatomic-pathophysiological...
Results of two-year study show Zilver Vena Venous Stent is safe...
The results of a two-year study support the continued safety and effectiveness of the Zilver Vena Venous Stent (Cook Medical) in treating symptomatic iliofemoral...
IVUS use in venous procedures improves stent patency
A recent study on iliac vein stenting showed better short- and mid-term patency rates when intravascular ultrasound (IVUS) was utilised prior to stent deployment...
Deep venous stenting presents advantage over ablation in achieving better ulcer...
“Venous leg ulcers (VLUs) secondary to deep venous stenosis represents a distinct class of patients who require a unique treatment paradigm,” stated Abhisekh Mohapatra...
Contralateral limb improvement after unilateral iliac vein stenting argues against simultaneous...
A retrospective review of patients presenting with bilateral obstructive iliofemoral venous lesions has shown that contralateral limb symptoms improve following stenting of the worse...
IVUS helps to reduce radiation exposure “significantly” for patients undergoing venous...
Michael Lichtenberg (Arnsberg, Germany) talks to BLearning Venous at LINC 2020 (Leipzig Interventional Course; 28–31 January 2020, Leipzig, Germany) about the rationale behind his...
Mid-term follow-up data for venous stent confirms high patency in line...
Clinical outcomes with the Vici venous stent system (Boston Scientific) have been described as “very good”, according to a presentation of 24- and 36-month...
VIVA 2019: Competition in the venous stenting space “will ultimately benefit...
Raghu Kolluri (Columbus, USA) and John Kaufman (Portland, USA) talk to BLearning Venous about the highlights from The VEINS (Venous Endovascular INterventional Strategies) session...
VEST external stent demonstrates low event and disease rates in two...
Clinical data presented at the 2019 European Cardio-Thoracic Surgery (EACTS) annual meeting (3-5 October, Lisbon, Portugal), from two prospective trials of the VEST external...
Thrombophilia not an independent risk factor for venous stent patency loss...
A recent study has concluded that patients with inherited or acquired thrombophilia should not be excluded from ilio-femoral venous stenting, Adam Gwozdz (St Thomas’...
Vesper Medical announces US$37 million financing with Vensana Capital and Gilde...
Vesper Medical, a developer of medical devices for minimally invasive peripheral vascular procedures, has announced a US$37 million financing with Vensana Capital and Gilde...
VIRTUS 12-month outcomes presented at LINC: Vici stent meets primary endpoints
New 12-month data from the VIRTUS trial demonstrates that patients who were treated with the Vici Venous Stent system (Boston Scientific) for iliac and femoral...
VERNACULAR trial 12-month data show successful use of Venovo stent in...
The 12-month results from the VERNACULAR trial have shown that the Venovo venous stent (BD Interventional) is successful when deployed in obstructive iliac and...
Worse outcomes in peripartum compared to non-pregnant women stented for DVT
Peripartum women with deep vein thrombosis (DVT) treated with catheter-directed thrombolysis and venous stenting had significantly increased rates of reintervention and loss of stent patency...
New intravascular ultrasound-based scoring system may predict future venous stent failure
To accompany the growing importance of intravascular ultrasound (IVUS) as an adjuvant diagnostic tool when treating deep venous disease, a study sought to create...
Reviewing five years of deep venous stenting: What comes next?
For many venous specialists, dedicated venous stents represent the future—and the promise of an ideal venous stent on the horizon is a central topic...
Use of IVUS to optimise outcomes in venous stenting
Intravascular ultrasound (IVUS) imaging technology provides the current gold standard technique for detection and characterisation of venous disease, Erin Murphy writes. In this article,...
UIP audience votes against stenting as standard for deep vein obstruction
The deep venous world is wrestling with the question: To stent or not to stent. While the availability of new specialised venous stents is...
First-in-man usage of blueflow venous stent
Following the announcement of receiving the CE mark in early 2018, ab medica has now reported the first-in man usage of its blueflow Venous...
One-year data from venous stent registry “promising”
Efficacy data from the Arnsberg Registry at 12 months are promising, with high primary patency rates for a dedicated venous stent.
Presenting the data at...
IDE study to evaluate Abre Venous Self-Expanding Stent in patients with...
Medtronic has announced the initiation of its investigational device exemption (IDE) study for the Abre venous self-expanding stent system. The ABRE IDE Study will...
Identifying standard practices of antithrombotic therapy post-venous stenting
Venous stenting has evolved over the last 15 years, quickly becoming an established procedure, with Class II recommendations from the American Heart Association and...
New research indicates that stenting below the inguinal ligament does not...
Endovascular treatment of iliocaval and infrainguinal post-thrombotic venous obstruction results do not appear to be adversely affected by extension of the iliac vein stents...
Decision-making in the choice of anticoagulants following deep venous stenting
Deep venous stenting has become increasingly used to treat patients with pathological obstruction of venous return in the femoro-iliocaval venous segment following the development of new...